Key result
Delayed diagnosis of arrhythmogenic cardiac sarcoidosis was associated with severe disease progression, with 7 of 10 late-diagnosis patients experiencing cardiac deterioration and 5 dying.
Why the study?
Cardiac sarcoidosis is a known cause of ventricular tachycardia, but an arrhythmogenic presentation may not prompt immediate comprehensive evaluation.
Does early diagnosis of arrhythmogenic cardiac sarcoidosis improve clinical outcomes and cardiac function compared to late diagnosis?
Observational (n=15)
Does early diagnosis of arrhythmogenic cardiac sarcoidosis improve clinical outcomes and cardiac function compared to late diagnosis?
Delayed diagnosis of arrhythmogenic cardiac sarcoidosis is common and associated with irreversible cardiac dysfunction and high mortality.
Answers are grounded in this paper and cite their sources.
Prompt evaluation for sarcoidosis is warranted in unexplained VT; retrospective data leaves open optimal diagnostic timing and outcomes.
AIMS: Cardiac sarcoidosis (CS) is a known cause of ventricular tachycardia (VT). However, an arrhythmogenic presentation may not prompt immediate comprehensive evaluation. We aimed to assess the diagnostic and disease course of patients with arrhythmogenic cardiac sarcoidosis (ACS). METHODS AND RESULTS: From the Leiden VT-ablation-registry, consecutive patients with CS as underlying aetiology were retrospectively included. Data on clinical presentation, time-to-diagnosis, cardiac function, and clinical outcomes were collected. Patients were divided in early (<6 months from first cardiac presentation) and late diagnosis. After exclusion of patients with known causes of non-ischaemic cardiomyopathy (NICM), 15 (12%) out of 129 patients with idiopathic NICM were ultimately diagnosed with CS and included. Five patients were diagnosed early; all had early presentation with VTs. Ten patients had a late diagnosis with a median delay of 24 (IQR 15-44) months, despite presentation with VT (n = 5) and atrioventricular block (n = 4). In 6 of 10 patients, reason for suspicion of ACS was the electroanatomical scar pattern. In patients with early diagnosis, immunosuppressive therapy was immediately initiated with stable cardiac function during follow-up. Adversely, in 7 of 10 patients with late diagnosis, cardiac function deteriorated before diagnosis, and in only one cardiac function recovered with immunosuppressive therapy. Six (40%) patients died (five of six with late diagnosis). CONCLUSION: Arrhythmogenic cardiac sarcoidosis is an important differential diagnosis in NICM patients referred for VT ablation. Importantly, the diagnosis is frequently delayed, which leads to a severe disease course, including irreversible cardiac dysfunction and death. Early recognition, which can be facilitated by electroanatomical mapping, is crucial.
No takes yet. Share an insight, caveat, or question.
Hoogendoorn et al. (2020) conducted an observational in Arrhythmogenic cardiac sarcoidosis (n=15). Delayed diagnosis vs. Early diagnosis (<6 months from first cardiac presentation) was evaluated on Clinical outcomes including cardiac function and death. Delayed diagnosis of arrhythmogenic cardiac sarcoidosis was associated with severe disease progression, with 7 of 10 late-diagnosis patients experiencing cardiac deterioration and 5 dying.
Synapse has enriched 10 related papers. Consider them for comparative context: